Technical Analysis for RFL - Rafael Holdings, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.70 | -1.73% | -0.03 |
RFL closed down 1.73 percent on Monday, March 18, 2024, on 84 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Gapped Down | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -1.73% | |
MACD Bullish Signal Line Cross | Bullish | -1.73% | |
Up 3 Days in a Row | Strength | -1.73% | |
20 DMA Resistance | Bearish | -1.16% | |
Stochastic Buy Signal | Bullish | -1.16% |
Alert | Time |
---|---|
Possible NR7 | 4 days ago |
Possible Inside Day | 4 days ago |
Rose Above 20 DMA | 4 days ago |
10 DMA Support | 4 days ago |
20 DMA Resistance | 4 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/12/2024
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.52 |
52 Week Low | 1.45 |
Average Volume | 29,133 |
200-Day Moving Average | 1.94 |
50-Day Moving Average | 1.78 |
20-Day Moving Average | 1.73 |
10-Day Moving Average | 1.70 |
Average True Range | 0.07 |
RSI (14) | 43.82 |
ADX | 21.05 |
+DI | 12.64 |
-DI | 11.94 |
Chandelier Exit (Long, 3 ATRs) | 1.68 |
Chandelier Exit (Short, 3 ATRs) | 1.85 |
Upper Bollinger Bands | 1.81 |
Lower Bollinger Band | 1.64 |
Percent B (%b) | 0.35 |
BandWidth | 9.68 |
MACD Line | -0.03 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0012 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.81 | ||||
Resistance 3 (R3) | 1.82 | 1.79 | 1.79 | ||
Resistance 2 (R2) | 1.79 | 1.77 | 1.79 | 1.78 | |
Resistance 1 (R1) | 1.75 | 1.75 | 1.74 | 1.74 | 1.78 |
Pivot Point | 1.72 | 1.72 | 1.72 | 1.72 | 1.72 |
Support 1 (S1) | 1.68 | 1.70 | 1.67 | 1.67 | 1.62 |
Support 2 (S2) | 1.65 | 1.68 | 1.65 | 1.62 | |
Support 3 (S3) | 1.61 | 1.65 | 1.61 | ||
Support 4 (S4) | 1.60 |